Subgroup Analyses of Efficacy Outcomes by Baseline Tumor Size in the Phase 3, Open-Label CLEAR Trial.
Journal of Clinical Oncology（2024）
Key words
281-318-9705,261-492-3532-2370-7650-2700,261-492-2769,261-492-5651-9764-9728,261-492-9019,137,3615,307
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined